Literature DB >> 32434988

Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis.

Tomasz Skirecki1, Patrycja Swacha2, Grażyna Hoser1, Jakub Golab3, Dominika Nowis4,5, Ewa Kozłowska2.   

Abstract

Sepsis survivors suffer from increased vulnerability to infections, and lymphopenia presumably contributes to this problem. The mechanisms of the recovery of memory CD4+ T cells after sepsis remain elusive. We used the cecal ligation and puncture mouse model of sepsis to study the restoration of the memory CD4+ T cells during recovery from sepsis. Then, adoptive transfer of antigen-specific naive CD4+ T cells followed by immunization and BrdU labeling were performed to trace the proliferation and migration of memory CD4+ T cells. We revealed that the bone marrow (BM) is the primary site of CD4+ memory T cell homing and proliferation after sepsis-induced lymphopenia. Of interest, BM CD4+ T cells had a higher basal proliferation rate in comparison with splenic T cells. These cells also show features of resident memory T cells yet have the capacity to migrate outside the BM niche and engraft secondary lymphoid organs. The BM niche also sustains viability and functionality of CD4+ T cells. We also identified IL-7 as the major inducer of proliferation of the BM memory CD4+ T cells and showed that recombinant IL-7 improves the recovery of these cells. Taken together, we provide data on the mechanism and location of memory CD4+ T cell proliferation during recovery from septic lymphopenia, which are of relevance in studying immunostimulatory therapies in sepsis.

Entities:  

Keywords:  Bone marrow; Immunology; Infectious disease; Memory; T cells

Mesh:

Year:  2020        PMID: 32434988      PMCID: PMC7259529          DOI: 10.1172/jci.insight.134475

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  72 in total

1.  Bone marrow as a priming site for T-cell responses to blood-borne antigen.

Authors:  Markus Feuerer; Philipp Beckhove; Natalio Garbi; Yolanda Mahnke; Andreas Limmer; Mirja Hommel; Günter J Hämmerling; Bruno Kyewski; Alf Hamann; Viktor Umansky; Volker Schirrmacher
Journal:  Nat Med       Date:  2003-08-10       Impact factor: 53.440

2.  Animal research: reporting in vivo experiments--the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  J Cereb Blood Flow Metab       Date:  2011-01-05       Impact factor: 6.200

3.  Recognizing Sepsis as a Global Health Priority - A WHO Resolution.

Authors:  Konrad Reinhart; Ron Daniels; Niranjan Kissoon; Flavia R Machado; Raymond D Schachter; Simon Finfer
Journal:  N Engl J Med       Date:  2017-06-28       Impact factor: 91.245

4.  Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans.

Authors:  Ineke den Braber; Tendai Mugwagwa; Nienke Vrisekoop; Liset Westera; Ramona Mögling; Anne Bregje de Boer; Neeltje Willems; Elise H R Schrijver; Gerrit Spierenburg; Koos Gaiser; Erik Mul; Sigrid A Otto; An F C Ruiter; Mariette T Ackermans; Frank Miedema; José A M Borghans; Rob J de Boer; Kiki Tesselaar
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

5.  T cell assays and MIATA: the essential minimum for maximum impact.

Authors:  C M Britten; S Janetzki; L H Butterfield; G Ferrari; C Gouttefangeas; C Huber; M Kalos; H I Levitsky; H T Maecker; C J M Melief; J O'Donnell-Tormey; K Odunsi; L J Old; T H M Ottenhoff; C Ottensmeier; G Pawelec; M Roederer; B O Roep; P Romero; S H van der Burg; S Walter; A Hoos; M M Davis
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

Review 6.  Current gaps in sepsis immunology: new opportunities for translational research.

Authors:  Ignacio Rubio; Marcin F Osuchowski; Manu Shankar-Hari; Tomasz Skirecki; Martin Sebastian Winkler; Gunnar Lachmann; Paul La Rosée; Guillaume Monneret; Fabienne Venet; Michael Bauer; Frank M Brunkhorst; Matthijs Kox; Jean-Marc Cavaillon; Florian Uhle; Markus A Weigand; Stefanie B Flohé; W Joost Wiersinga; Marta Martin-Fernandez; Raquel Almansa; Ignacio Martin-Loeches; Antoni Torres; Evangelos J Giamarellos-Bourboulis; Massimo Girardis; Andrea Cossarizza; Mihai G Netea; Tom van der Poll; André Scherag; Christian Meisel; Joerg C Schefold; Jesús F Bermejo-Martín
Journal:  Lancet Infect Dis       Date:  2019-10-17       Impact factor: 25.071

7.  Increased attrition of memory T cells during sepsis requires 2B4.

Authors:  Jianfeng Xie; Ching-Wen Chen; Yini Sun; Sonia J Laurie; Wenxiao Zhang; Shunsuke Otani; Gregory S Martin; Craig M Coopersmith; Mandy L Ford
Journal:  JCI Insight       Date:  2019-05-02

8.  Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization.

Authors:  Matthew A Huggins; Frances V Sjaastad; Mark Pierson; Tamara A Kucaba; Whitney Swanson; Christopher Staley; Alexa R Weingarden; Isaac J Jensen; Derek B Danahy; Vladimir P Badovinac; Stephen C Jameson; Vaiva Vezys; David Masopust; Alexander Khoruts; Thomas S Griffith; Sara E Hamilton
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

9.  Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection.

Authors:  Stephanie A Condotta; Deepa Rai; Britnie R James; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

10.  Memory T-cell competition for bone marrow seeding.

Authors:  Francesca Di Rosa; Angela Santoni
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

View more
  5 in total

1.  TLR2-induced CD8+ T-cell deactivation shapes dendritic cell differentiation in the bone marrow during sepsis.

Authors:  Anne-Charlotte Antoni; Ekaterina Pylaeva; Bettina Budeus; Jadwiga Jablonska; Ludger Klein-Hitpaß; Marcel Dudda; Stefanie B Flohé
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

Review 2.  Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options.

Authors:  Di Liu; Si-Yuan Huang; Jian-Hui Sun; Hua-Cai Zhang; Qing-Li Cai; Chu Gao; Li Li; Ju Cao; Fang Xu; Yong Zhou; Cha-Xiang Guan; Sheng-Wei Jin; Jin Deng; Xiang-Ming Fang; Jian-Xin Jiang; Ling Zeng
Journal:  Mil Med Res       Date:  2022-10-09

Review 3.  Sepsis and multiple sclerosis: Causative links and outcomes.

Authors:  Đorđe Miljković; Suzana Stanisavljević; Isaac J Jensen; Thomas S Griffith; Vladimir P Badovinac
Journal:  Immunol Lett       Date:  2021-07-25       Impact factor: 4.230

4.  Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells.

Authors:  Isaac J Jensen; Samantha N Jensen; Frances V Sjaastad; Katherine N Gibson-Corley; Thamothrampillai Dileepan; Thomas S Griffith; Ashutosh K Mangalam; Vladimir P Badovinac
Journal:  Elife       Date:  2020-11-16       Impact factor: 8.713

5.  An Early Myelosuppression in the Acute Mouse Sepsis Is Partly Outcome-Dependent.

Authors:  Tomasz Skirecki; Susanne Drechsler; Aldona Jeznach; Grażyna Hoser; Mohammad Jafarmadar; Jerzy Kawiak; Marcin F Osuchowski
Journal:  Front Immunol       Date:  2021-07-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.